2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 2265

Prevalence and Physical and Mental Health Patterns of Rheumatic and Musculoskeletal Diseases in Portugal: Results from a National Health Survey
Abstract Number: 2266

Is Rheumatic Disease Really More Severe in Indigenous Populations? a Systematic Review of Clinical Outcomes in Indigenous Populations of Canada, the United States, Australia and New Zealand
Abstract Number: 2267

Rheumatology Work Force Planning in Western Countries – a Systematic Literature Review
Abstract Number: 2268

Peripheral Joint MRI for Inflammatory Arthritis and the Choosing Wisely Campaign – Evidence for Wide Variations in Use
Abstract Number: 2269

Rheumatologists Consider Patient Preferences and Costs When Choosing Treatments for Rheumatoid Arthritis (RA) Patients. a Cross-European Discrete Choice Experiment
Abstract Number: 2270

Cardiovascular Disease: The Hidden Risk in Persons with Rheumatoid Arthritis
Abstract Number: 2271

Does Arthritis in the Young Adult Life Phase Impact Involvement in Transitional Social Roles?
Abstract Number: 2272

Physical Performance Contributes Only Marginally in Explaining Fatigue Variation in Persons with RA Moderately Affected By Their Disease
Abstract Number: 2273

The Effect of Widespread Pain on Incident Knee Pain and Knee Osteoarthritis: The Multicenter Osteoarthritis (MOST) Study
Abstract Number: 2274

Increasing Moderate-to-Vigorous Activity and Decreasing Sedentary Time Are Associated with 2-Year Weight Loss in Obese Persons with or at Risk for Knee Osteoarthritis
Abstract Number: 2275

The Burden of Axial Spondyloarthritis: A Comparison of the Radiographic and Non-Radiographic Groups
Abstract Number: 2276

The Association of Knee Pain and Knee Osteoarthritis with Incident Widespread Pain: The Multicenter Osteoarthritis (MOST) Study
Abstract Number: 2277

Working Harder to Stay in Control: Patient Reports of Flare in Early RA Are Associated with Higher Disease Activity and More Intensive Self Management
Abstract Number: 2278

Identification of Long-Term Physical Activity Trajectories in Individuals with Chronic Widespread Pain Who Received Exercise Treatment As Part of a Randomized Controlled Trial
Abstract Number: 2279

Impacts on Work: Arthritis Vs Chronic Joint Symptoms without Arthritis

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].